An agreement struck between the UK and EU on Northern Ireland has been welcomed by the British Generic Manufacturers Association as offering certainty for the industry and patients, easing pressures that had threatened to make supply to the region unviable.
Under the landmark post-Brexit “Windsor Framework” agreed by the UK and the EU, the UK Medicines and Healthcare products Regulatory...





